Ecnoglutide Guide
XANO Pharmaceuticals
Complete guide to Ecnoglutide. Ecnoglutide (XW003) is a long-acting GLP-1 receptor agonist developed by Sciwind Biosciences / XANO Pharmaceuticals. In ..
XANO Pharmaceuticals\' GLP-1 Receptor Agonist
Ecnoglutide (XW003) is a long-acting GLP-1 receptor agonist developed by Sciwind Biosciences / XANO Pharmaceuticals. In Phase 2 trials, it demonstrated up to approximately 16% weight loss over 24 weeks in adults with obesity. Its development adds to the growing global pipeline of GLP-1 therapies aiming to provide more accessible treatment options. Use the Shotlee app to track your current protocol and build baseline data for whatever comes next.
What Is Ecnoglutide?
Ecnoglutide (XW003) is a long-acting GLP-1 receptor agonist developed by Sciwind Biosciences / XANO Pharmaceuticals. In Phase 2 trials, it demonstrated up to approximately 16% weight loss over 24 weeks in adults with obesity. Its development adds to the growing global pipeline of GLP-1 therapies aiming to provide more accessible treatment options.
Track your current protocol in Shotlee while this science evolves. Having clean historical data means you can compare outcomes with precision if you ever switch medications.
How It Works
Clinical Data
Side Effects
Vital Protocol FAQs
Guide FAQs
Complete guide to Ecnoglutide. Ecnoglutide (XW003) is a long-acting GLP-1 receptor agonist developed by Sciwind Biosciences / XANO Pharmaceuticals. In ..
Yes. Shotlee supports tracking Ecnoglutide doses, side effects, and health metrics. It is free to use.
Track Your Ecnoglutide Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.